Stock Price Quote

LAURUS LABS LTD.

NSE : LAURUSLABSBSE : 540222ISIN CODE : INE947Q01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE434.50-2.6 (-0.59 %)
PREV CLOSE ( ) 437.10
OPEN PRICE ( ) 437.00
BID PRICE (QTY) 437.75 (4)
OFFER PRICE (QTY) 439.15 (12)
VOLUME 386
TODAY'S LOW / HIGH ( )434.50 439.65
52 WK LOW / HIGH ( )298 460
NSE438.100.95 (+0.22 %)
PREV CLOSE( ) 437.15
OPEN PRICE ( ) 438.10
BID PRICE (QTY) 438.10 (26)
OFFER PRICE (QTY) 439.45 (12)
VOLUME 330
TODAY'S LOW / HIGH( ) 438.10 438.10
52 WK LOW / HIGH ( )303.3 459.95
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 19-09 2005
Management Info
Malempati Venugopala Rao - Chairman - Managing Director
Registered Office

Address Plot No.21, J N Pharma City,Parawada, ,
Vishakhapatnam,
Andhra Pradesh-531021

Phone 0891 3061222

Email nagaraj.a@lauruslabs.com

Website www.lauruslabs.com

Registrars Details
KFIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE

NEWS

31Jan Laurus Labs reports over 4-fold jump i
Laurus Labs has reported results for third quarter ended December 31, 20..
24Jan Persistent Systems, S P Apparels and H
Persistent Systems and ValidSoft have jointly developed a secure digital..
23Jan Laurus Labs gets EIR from USFDA for Un
Laurus Labs has received an Establishment Inspection Report (EIR) (for t..
23Jan Laurus Labs Receives EIR From USFDA F
The Company is pleased to announce that it has received an Establishment..
20Jan Board Meeting Intimation for Approval
Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directo..

Financials

in Millions
QTR Dec 19 ANNUAL 19
Net Profit779.52949.94
Gross Profit 859.26 1212.19
Operating Profit 1530.23675.83
Net Sales 7209.9222361.48

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Solara Active Pharma (BSE)
peergroup  651.35 (5.31%)
M.Cap ( in Cr)1611.52
Medicamen Biotech (BSE)
peergroup  323.50 (2.88%)
M.Cap ( in Cr)384.15
Divis Lab (BSE)
peergroup  2155.00 (0.39%)
M.Cap ( in Cr)56985.49
Dr. Reddys Lab (BSE)
peergroup  3315.90 (0.25%)
M.Cap ( in Cr)54958.46
Glenmark Pharma (BSE)
peergroup  340.50 (2.05%)
M.Cap ( in Cr)9414.54

Shareholding Pattern

MUTUAL FUNDS/UTI 4.92%
PROMOTERS 32.58%
NON-INSTITUTION 24.8%
FI/BANKS/INSURANCE 0.08%
GOVERNMENT 0%
FII 0%

About Laurus Labs Ltd.

Laurus Labs Ltd. was incorporated in the year 2005. Its today's share price is 437.1. Its current market capitalisation stands at Rs 4673.23 Cr. In the latest quarter, company has reported Gross Sales of Rs. 22919.16 Cr and Total Income of Rs.23080.68 Cr. The company's management includes Ravindranath Kancherla, Ramesh Subrahmanian, Rajesh Koshy Chandy, Aruna Bhinge, Narendra Ostawal, Venkata Lakshmana Rao Chunduru, Chandrakanth Chereddi, Venkata Ravi Kumar Vantaram, Chava Satyanarayana, Malempati Venugopala Rao.

It is listed on the BSE with a BSE Code of 540222 , NSE with an NSE Symbol of LAURUSLABS and ISIN of INE947Q01010. It's Registered office is at Plot No.21, J N Pharma City,Parawada, Vishakhapatnam-531021, Andhra Pradesh. Their Registrars are ACC Ltd. It's auditors are Deloitte Haskins & Sells LLP, SR Batliboi & Associates LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X